Featured Intelligence

The longevity clinic industry has grown quickly, with an estimated eight hundred clinics now operating across the United States, many selling extensive imaging and biomarker testing packages as a form of proactive health insurance. Top-tier concierge memberships can run

Parkinson's disease progresses because a specific population of brain cells that produce dopamine gradually dies off, and no existing treatment replaces those cells, only manages the resulting symptoms. Two independent research programs are now testing a more direct

Rapamycin, an old immunosuppressant drug repurposed by longevity clinics as a low-dose anti-aging treatment, has become one of the most widely prescribed off-label longevity interventions available today. The theory behind it is genuinely serious science, it targets

Personalized mRNA cancer vaccines, built from a patient's own tumor rather than mass-produced, have moved past their early proof-of-concept stage and are now generating results that stretch out for years. Updated data on a pancreatic

For years, confirming whether someone's memory problems were actually caused by Alzheimer's disease meant an expensive brain scan or an invasive spinal tap. That changed with the clearance of blood tests measuring a protein called p-

For decades, a donated organ traveled from operating room to operating room the same simple way: packed on ice, racing against a clock before the tissue deteriorated too far to use. That basic method is now being replaced at many

A new weight-loss pill approved this year works through the same GLP-1 pathway as the injectable drugs that have reshaped obesity treatment, but it is built entirely differently at the molecular level, and that difference matters more than

CAR-T cell therapy was built to fight blood cancers, engineering a patient's own immune cells to hunt down and destroy cancerous B cells. This year, that same basic technology is producing real, closely watched results in a

Several competing companies have now implanted brain-computer interfaces in dozens of paralyzed patients who can genuinely control a computer cursor, type, and communicate using only their thoughts. Synchron's device has been placed in more than fifty patients